Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 July 2024 - 12:05

Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/byfavo

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters